SRPT vs. ML

Last updated Apr 1, 2026

Compare and contrast key facts about Sarepta Therapeutics, Inc. (SRPT) and MoneyLion Inc. (ML).

Performance

SRPT vs. ML - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sarepta Therapeutics, Inc. (SRPT) and MoneyLion Inc. (ML). The values are adjusted to include any dividend payments, if applicable.

SRPT vs. ML - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
SRPT Sarepta Therapeutics, Inc.	1.12%	-82.30%	26.09%	-25.58%	43.90%	-47.18%	8.59%
ML MoneyLion Inc.	0.00%	-0.13%	37.20%	237.04%	-84.62%	-64.34%	15.31%

Fundamentals

Total Revenue (TTM) SRPT : $2.20B ML : $545.91M
Gross Profit (TTM) SRPT : -$1.05B ML : $409.26M
EBITDA (TTM) SRPT : -$778.95M ML : $56.96M

Returns By Period

SRPT

• 1D: 6.25%
• 1M: 29.83%
• YTD: 1.12%
• 6M: 12.92%
• 1Y: -65.90%
• 3Y*: -45.95%
• 5Y*: -22.17%
• 10Y*: 0.86%

ML

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

SRPT vs. ML — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SRPT

SRPT Risk / Return Rank: 17
SRPT Sharpe Ratio Rank: 16
SRPT Sortino Ratio Rank: 20
SRPT Omega Ratio Rank: 18
SRPT Calmar Ratio Rank: 11
SRPT Martin Ratio Rank: 22

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SRPT vs. ML - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sarepta Therapeutics, Inc. (SRPT) and MoneyLion Inc. (ML). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	SRPT	ML	Difference
Sharpe ratio Return per unit of total volatility	-0.60	—	—
Sortino ratio Return per unit of downside risk	-0.47	—	—
Omega ratio Gain probability vs. loss probability	0.93	—	—
Calmar ratio Return relative to maximum drawdown	-0.85	—	—
Martin ratio Return relative to average drawdown	-1.09	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	SRPT	ML	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.60	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.32	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.01	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.02	—	—

Correlation

The correlation between SRPT and ML is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

SRPT vs. ML - Dividend Comparison

Neither SRPT nor ML has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

Drawdown Indicators

	SRPT	ML	Difference
Max Drawdown Largest peak-to-trough decline	-98.17%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-81.26%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-92.72%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-93.33%	—	—
Current Drawdown Current decline from peak	-87.83%	—	—
Average Drawdown Average peak-to-trough decline	-68.01%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	63.49%	—	—

Volatility

Volatility by Period

	SRPT	ML	Difference
Volatility (1M) Calculated over the trailing 1-month period	35.20%	—	—
Volatility (6M) Calculated over the trailing 6-month period	70.73%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	110.30%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	69.77%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	75.48%	—	—

Financials